📊 Definition & Pathophysiology
PAH = mean PAP ≥25 mmHg, PAWP <15, PVR >3 WU. RV failure is major determinant of mortality. Factors increasing PVR: hypoxia, acidosis, hypothermia, pain/agitation, atelectasis, overdistension.
🩸 Pulmonary Hypertensive Crisis (PHC)
Sudden increase in PVR → RV failure → decreased LV filling → hypotension, desaturation, bradycardia, arrest. Precipitated by hypoxia, acidosis, suctioning, pain, extubation, infection.
💊 Inhaled Pulmonary Vasodilators
• iNO (inhaled nitric oxide) 20 ppm — selective pulmonary vasodilator, no systemic hypotension
• Inhaled epoprostenol (prostacyclin) — cost-effective alternative to iNO
💉 Systemic Therapies
• Milrinone: inodilator + lusitropy, reduces PVR (but may cause systemic hypotension)
• Sildenafil (PDE5 inhibitor): 0.3-1 mg/kg PO/IV, inhibits cGMP breakdown
• Prostacyclin analogues: IV epoprostenol, treprostinil
• Endothelin receptor antagonists: bosentan (chronic)
⚠️ Crisis Management
1. 100% O2, intubate if needed
2. Correct acidosis (NaHCO3)
3. Deep sedation/paralysis to prevent agitation
4. iNO 20 ppm or inhaled epoprostenol
5. Milrinone or dobutamine for RV inotropy
6. Noradrenaline for systemic hypotension (maintain coronary perfusion)
📋 RV Failure Support
• Maintain preload (avoid hypovolaemia)
• Avoid hypocarbia (cerebral vasoconstriction) and hypercarbia (acidosis)
• Optimal lung volume (FRC) — avoid atelectasis and overdistension
• ECMO for refractory PHC